Close Server: KOPWWW05 | Not logged in


Welcome to Health Care POV | sign in | join
ADVANCE Perspective: Respiratory Views

BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial

Published September 16, 2016 12:43 PM by ADVANCE for Respiratory Care & Sleep Medicine

By ADVANCE Perspectives

 

Big news from BD! The company, along with Vancive Medical Technologies, has launched a line of transparent vascular dressings with chlorhexidine gluconate (CHG) antimicrobial preservative that are designed to enhance patient care and be easy for clinicians to apply and remove. This comes as welcome news to patients receiving long-term care for their vascular conditions.

 

The new BD ChloraShield dressings, which feature the innovative adhesive BeneHold CHG technology developed by Vancive Medical Technologies, comfortably secure the dressing to the skin, absorb fluids and protect the site from external contaminants. The CHG incorporated within the adhesive preserves the dressing from microbial growth, making them well-suited for catheter insertion sites. The Infusion Nurses Society recently released guidelines recommending the use of CHG dressings. BD is the exclusive distributor of the dressings worldwide.

 

SEE ALSO: 3D Printing Advances in Healthcare

 

 "The combination of vascular access expertise from BD, infection prevention expertise from the CareFusion acquisition and CHG adhesive technology from Vancive Medical Technologies creates a powerful combination for a new vascular access product," said Stephen Hartley, global vice president of Infection Prevention for BD. "The new ChloraShield IV dressings complete BD's portfolio to offer a comprehensive set of products for vascular access procedures, including skin prep, catheters, connectors and flush products."

 

BD ChloraShield dressings are available in a variety of designs including bordered and non-bordered as well as sizes commonly used for peripheral IVs and PICCs.

 

"BeneHold CHG adhesive technology is well-suited for vascular access dressings," said Kirsten Newquist general manager for Vancive Medical Technologies. "The collaboration with BD brings together complementary expertise from both companies and we look forward to expanding the product offerings in the future."

 

ADVANCE Opinion Poll: What is the biggest reason for patient non-compliance with CPAP?

 

BD and Vancive Medical Technologies will showcase the new BD ChloraShield dressings in booth #423 at the 30th annual Association for Vascular Access Conference, being held September 16–19 in Orlando, Florida.

 

You Might Also Like...

Failure to Communicate

The potential blind spot in population health management strategies.

Taking the Next Step to Population Health

CINs are surging as hospitals and physicians navigate the shift from fee-for-service to value-based care.

A True Collaboration

Do patients really want to be engaged?

Respiratory Therapist Workforce Report

Projected outlook is a breath of fresh air for people considering this line of work.

0 comments

leave a comment



To prevent comment spam, please type the code you see below into the code field before submitting your comment. If you cannot read the numbers in the image, reload the page to generate a new one.

Captcha
Enter the security code below:
 

Search

About this Blog

Keep Me Updated